Korean J Urol.
1986 Oct;27(5):663-668.
BCG(Bacillus Calmette-Guerin) for Superficial Transitional Cell Carcinoma of the Bladder: A Preliminary Report(I)
- Affiliations
-
- 1Department of Urology, Keimyung University School of Medicine, Taegu, Korea.
Abstract
- Tice-Chicago strain bacillus Calmette-Guerin was used to treat superficial transitional cell carcinoma of the bladder in 11 patients. The treatment regimen of 120mg. Tice-Chicago strain bacillus Calmette-Guerin weekly for 6 weeks and then monthly for 3 months was well tolerated. Side effects during or shortly after treatment were minor and self-limiting in the majority of patients (fever, bladder irritability and hematuria). Although the findings are still preliminary, they appear to hold promise of a new therapeutic approach to the treatment of a group of carcinoma of the bladder for which effective therapy is still lacking in this country.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- BCG(Bacillus Calmette-Guerin) for Superficial Transitional Cell Carcinoma of the Bladder
- The Significance of Repeat Bladder Biopsy after Intravesical Bacillus Calmette-Guerin Therapy for High Risk Superficial Transitional Cell Carcinoma of Bladder
- Effect of Intraperitoneal and Intravesical Bacillus Calmette-Guerin on Bladder Carcinogenesis in Rats Induced by N-butyl-N-(4-hydroxybutyl) nitrosamine
- Tuberculous Prostatic Abscess Following Intravesical Bacillus Calmette-Guerin Instillation
- Effect of BCG Immunotherapy on the Cytokine Production and Antitumor Activity against MBT - 2 Mouse Bladder Tumor
